These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities. Yazici Y, Erkan D, Harrison MJ, Nikolov NP, Paget SA. Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122 [Abstract] [Full Text] [Related]
6. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate. Lynch M, Kirby B. Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119 [No Abstract] [Full Text] [Related]
7. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate. Amital H, Arnson Y, Chodick G, Shalev V. Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136 [Abstract] [Full Text] [Related]
8. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis. Osuga T, Ikura Y, Kadota C, Hirano S, Iwai Y, Hayakumo T. Int J Clin Exp Pathol; 2015 Sep; 8(2):1961-6. PubMed ID: 25973089 [Abstract] [Full Text] [Related]
12. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Ezhilarasan D. Toxicology; 2021 Jun 30; 458():152840. PubMed ID: 34175381 [Abstract] [Full Text] [Related]
13. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate. Gupta R, Gupta SK. MedGenMed; 2005 Sep 06; 7(3):9. PubMed ID: 16369235 [No Abstract] [Full Text] [Related]
14. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective. Lewis JH. J Rheumatol; 1997 Aug 06; 24(8):1459-60. PubMed ID: 9263133 [No Abstract] [Full Text] [Related]